We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+14.59%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$267M
AUM Growth
+$24.2M
Cap. Flow
-$6.57M
Cap. Flow %
-2.46%
Top 10 Hldgs %
59.27%
Holding
119
New
12
Increased
26
Reduced
8
Closed
10

Top Buys

Rank Stock Value
1
DELL icon
Dell
DELL
+$9.45M
2
MITL
Mitel Networks Corporation
MITL
+$5M
3
ORCL icon
Oracle
ORCL
+$4.61M
4
MPLX icon
MPLX
MPLX
+$3.48M
5
MIK
Michaels Stores, Inc
MIK
+$2.85M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$37.4M
2
FTAI icon
FTAI Aviation
FTAI
+$7.99M
3
PFE icon
Pfizer
PFE
+$5.04M
4
META icon
Meta Platforms (Facebook)
META
+$3.2M
5
GSK icon
GSK
GSK
+$883K

Sector Composition

Rank Sector Weight
1 Healthcare 43.57%
2 Technology 15.76%
3 Energy 7.9%
4 Financials 7.76%
5 Miscellaneous 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
26
Viking Therapeutics
VKTX
$3.75B
$2.34M 0.88%
246,600
+4,600
+2% +$30.6K
CHCT
27
Community Healthcare Trust
CHCT
$428M
$1.79M 0.67%
60,000
– –
CXW icon
28
CoreCivic
CXW
$3.34B
$1.79M 0.67%
75,000
– –
CPRX
29
DELISTED
Catalyst Pharmaceutical
CPRX
$1.6M 0.6%
513,475
+24,900
+5% +$75.5K
XENE icon
30
Xenon Pharmaceuticals
XENE
$5.81B
$1.59M 0.6%
173,390
+58,490
+51% +$363K
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.51M 0.57%
34,691
+8,649
+33% +$372K
STML
32
DELISTED
Stemline Therapeutics, Inc.
STML
$1.45M 0.54%
90,000
– –
AB icon
33
AllianceBernstein
AB
$3.43B
$1.44M 0.54%
50,500
– –
QTNT
34
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.34M 0.5%
4,175
+175
+4% +$41K
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.22M 0.46%
+73,640
New +$1.12M
CNQ icon
36
Canadian Natural Resources
CNQ
$101B
$1.17M 0.44%
66,059
– –
EIGR
37
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.12M 0.42%
3,059
+997
+48% +$355K
AIMT
38
DELISTED
Aimmune Therapeutics
AIMT
$1.1M 0.41%
40,780
+11,000
+37% +$337K
RHP icon
39
Ryman Hospitality Properties
RHP
$8.92B
$1.03M 0.39%
12,400
– –
ZGNX
40
DELISTED
Zogenix, Inc.
ZGNX
$972K 0.36%
22,000
+2,000
+10% +$82.4K
VZ icon
41
Verizon
VZ
$208B
$921K 0.35%
18,311
– –
JNJ icon
42
Johnson & Johnson
JNJ
$646B
$883K 0.33%
7,280
– –
XRN.PRA
43
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$869K 0.33%
35,000
– –
CNCE
44
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$868K 0.33%
51,557
+2,000
+4% +$38.8K
XLRN
45
DELISTED
Acceleron Pharma
XLRN
$796K 0.3%
+16,400
New +$598K
IMMU
46
DELISTED
Immunomedics Inc
IMMU
$752K 0.28%
31,783
-26,700
-46% -$537K
ONCT
47
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$735K 0.28%
343
+272
+383% +$690K
SVC
48
Service Properties Trust
SVC
$1.02B
$715K 0.27%
5,000
– –
T icon
49
AT&T
T
$178B
$708K 0.27%
29,194
– –
UAL icon
50
United Airlines
UAL
$35.9B
$697K 0.26%
10,000
– –
1
2
3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2018 Portfolio in Review

As of Q2 2018, David M. Knott held 119 positions worth $267M, up 10% from $243M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

David M. Knott's Q2 2018 filing shows 12 new, 26 increased, 8 reduced and 10 closed positions. Its largest new stake was Dell: 427,589 shares worth $10.2M. The largest sale was Ligand Pharmaceuticals, an estimated $37.4M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 56% a quarter earlier, followed by Technology and Energy.

  • David M. Knott's largest Q2 2018 buy was Dell: 427,589 shares worth $10.2M.
  • David M. Knott added most to Mitel Networks Corporation in Q2 2018, an estimated $5M increase.
  • David M. Knott's biggest Q2 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $37.4M.
  • David M. Knott fully exited FTAI Aviation in Q2 2018, selling an estimated $7.99M.
  • David M. Knott's ten largest holdings make up 59% of its $267M portfolio in Q2 2018.
  • David M. Knott opened 12 new positions and closed 10 in Q2 2018.
  • David M. Knott's portfolio value rose 10% quarter-over-quarter to $267M.

Based on David M. Knott's 13F filing for Q2 2018, filed 13 Aug 2018.